News

NEWS
Education
June 2, 2021
InSysBio's student to defend diploma thesis
Elena Vasileva, student of Lomonosov Moscow State University (MSU) has developed her diploma thesis in InSysBio and successfully passed its defense. Her diploma thesis entitled “Optimization of anti-CD47 therapeutic agent dosage using PK/PD modeling” was supervised by Oleg Demin Jr, Head of Oncology and Immuno-Oncology at InSysBio.
LEARN MORE
NEWS
Press-Release
May 19, 2021
InSysBio to upgrade its SbmlViewer application
[Moscow – 19.05.2021] InSysBio, one of the world’s pioneers of Quantitative Systems Pharmacology (QSP) modeling, launches the new version (0.3.0) of its SbmlViewer open project. Generally, SbmlViewer is a tool for fast and easy reading and transformation of biological models written in SBML format.
LEARN MORE
NEWS
Press-Release
April 6, 2021
InSysBio to present Heta compiler version 0.6
InSysBio presents the major updates of Heta compiler. Heta compiler is a software tool for development of QSP modeling platforms. In fact, its core option is the compilation of Heta-based platforms. Its functionality has been significantly elaborated and now Heta compiler has become even more useful and functional.
LEARN MORE
NEWS
Press-Release
March 30, 2021
InSysBio to launch Immune Response Template 3.4.0
IRT gets new data and recalculated parameters [Moscow – 30.03.2021] InSysBio, one of the world’s pioneers of Quantitative Systems Pharmacology (QSP) modeling, launches Immune Response Template (IRT) version 3.4.0. IRT represents a Quantitative Systems Pharmacology (QSP) platform of immune system simultaneously being a tool for development of models related to immune system. IRT is based on two main components.
LEARN MORE
NEWS
Press-Release
February 15, 2021
InSysBio to be interviewed in frames of INNOVATORS VS COVID-19 series
[Moscow – 15.02.2021] Oleg Demin Jr, Head of Oncology and Immuno-Oncology at InSysBio, one of the world’s pioneers of Quantitative Systems Pharmacology (QSP) modeling, has talked to startup.info, a global innovation ecosystem magazine. The interview in frames of the series "INNOVATORS VS COVID-19" covers the application of system-pharmacology modeling to different stages of drug research and development and InSysBio's current development in the context of the pandemic.
LEARN MORE
NEWS
Press-Release
January 26, 2021
InSysBio to announce the upgrade of its SbmlViewer application to version 0.2.7
[Moscow – 26.01.2021] InSysBio, one of the world’s pioneers of Quantitative Systems Pharmacology (QSP) modeling, launces the new version of its SbmlViewer open project. Generally, SbmlViewer represents a tool for fast and easy reading of biological models written in SBML format.
LEARN MORE
November 2022
MoTuWeThFrSaSu
 
1
2
3
4
5
6
7
8
9
1. 09 Nov 2022 13:21 InSysBio to start the operation of new Headquarters and new branch office InSysBio announces the start of operation of Headquarters in the United Kingdom. At the same time, the new branch office has been founded in Cyprus and part of InSysBio team has relocated there, thus, expanding the company’s presence.
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
    
Upcoming Events
Tags